1[1]Beuers U, Boyer JL, Paumgartner G. Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic application[J]. Hepatology, 1998, 28:1449-1453.
2[2]Paumgartner G. Ursodeoxycholic acid treatment of primary biliary cirrhosis: potential mechanisms of action [ M ]. In: LindorKD,Heathcote Ej, Poupon R, eds. Primary Biliary Cirrhosis: From Pathogenesis to Clinical Treatment. Dordrecht: Kluwer Academic Publishers, 1998.138 - 146.
3[3]Tanaka M, Nakura H, Tateishi T, et al. Ursodeoxycholic acid prevents hepatic cytochrome P450 isozyme reduction in rats with deoxycholic acid- induced liver injury[J]. J Hepatol, 1999, 31 (2):263 - 270.
4[4]Rodrigues CM, Fan G, Ma X, et al. A novel role for ursodeoxycholic acid in inhibiting mitochondrial membrane perturbation[J]. J Clin Invest, 1998, 101:2790- 2799.
5[5]Angulo P, Lindor KD. Managent of primary biliary cirrhosis and antoimmune cholangitis[J]. Clin Liver Dis, 1998, 2:333 - 351.
6[6]Combes B, Carithers RL Jr, Maddrey WC, et al. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid[J]. Hepatology, 1999, 29(6): 1649 - 1654.
7[7]Degott C, Zafrani ES, Callard P, et al. Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression[J]. Hepatology, 1999, 29(4):1007- 1012.
8[8]Angulo P, Batts KP, Therneau TM, et al. Long term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis [J]. Hepatology, 1999, 29(3):644-647.
9[9]Pasha T, Heathcote J, Gabriel S, et al. Cost effectiveness of ursodeoxycholic acidtherapyinprimary biliary cirrhosis[J].Hepatology,1999,29(1):21-26.
10[10]Lindor KD.Ursodial for primary sclerosingcholangitis.Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group[J].NEJM,1997,336:691-695.
